Summit Therapeutics shares owned by HighTower Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by HighTower Advisors
from 13F filings
Historical chart of HighTower Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Summit Therapeutics by HighTower Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $265k | 64k | 4.14 |
2023-12-31 | $31k | 12k | 2.59 |